Jefferies Healthcare Conference, Day 2: Myriad; Danaher; Cepheid; Exact Sciences
June 07, 2011
Jefferies Healthcare Conference, Day 2: Myriad; Danaher; Cepheid; Exact Sciences
Myriad and Cepheid discussed their pipelines, while Exact Sciences provided some details of its upcoming trial on its colon cancer test, and Danaher touted its success with past acquisitions as it nears closing of its Beckman Coulter buy.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- In Brief This Week: Exact Sciences, Hologic; Myriad Genetics; Cepheid; Bio-Rad Laboratories; Ambry Genetics; GNS Healthcare; Horizon Discovery; Interleukin Genetics; Kreatech; BioSignatures
March 8, 2013 / GenomeWeb Daily News - Investment Firm Jefferies Resumes Coverage on Eight MDx, Genetic Testing, Tools Firms
March 11, 2011 / GenomeWeb Daily News - JP Morgan Healthcare Conference, Day Three: Foundation Medicine, Luminex, PerkinElmer, Danaher, Quidel, Ariosa, BioFire, Atossa, Exact Sciences
January 10, 2013 / GenomeWeb Daily News - People in the News: Eric Bouvier; Alan Marshall; and More
January 13, 2012 / ProteoMonitor - Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor